antimicrobial resistance

Novartis antibiotic retreat doesn’t stop Sandoz buying GSK drugs

https://pharmaphorum.com/news/novartis-antibiotic-retreat-doesnt-stop-sandoz-buying-gsk-drugs/

1 week to SMi’s Superbugs & Superdrugs – REMOTE ACCESS ONLY

https://pharmaphorum.com/partner-content/1-week-to-smis-superbugs-superdrugs-remote-access-only/

Interview with Martin Everett speaker at SMi’s Superbugs & Superdrugs Conference

https://pharmaphorum.com/partner-content/interview-with-martin-everett-speaker-at-smis-superbugs-superdrugs-conference/

Still too little progress on antibiotic resistance, says O’Neill report update

https://pharmaphorum.com/news/still-too-little-progress-on-antibiotic-resistance-says-oneill-report-update/

FDA okays Nabriva’s novel antibiotic Xenleta for pneumonia

https://pharmaphorum.com/news/fda-okays-nabrivas-novel-antibiotic-xenleta-for-pneumonia/

Who will pay the price for inaction on superbugs?

https://pharmaphorum.com/r-d/views-analysis-r-d/who-will-pay-the-price-for-inaction-on-superbugs/

As R&D shrinks, UK trials new payment scheme for antibiotics

https://pharmaphorum.com/news/as-rd-shrinks-uk-trials-new-payment-scheme-for-antibiotics/

AMR research and Matoke Pharma: the pharmaphorum podcast

https://pharmaphorum.com/podcast/amr-research-matoke-pharma-podcast/

Discuss recent developments in bacterial immunotherapy at Superbugs & Superdrugs 2019

https://pharmaphorum.com/partner-content/discuss-recent-developments-in-bacterial-immunotherapy-at-superbugs-superdrugs-2019/

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search